A questionnaire survey was conducted to identify issues in counseling sales of Dimetotiazine, a headache prophylaxis drug that is being considered as a candidate for a switch OTC drug, suggesting that the ability to distinguish between migraine and other types of headaches may make a difference in the way patients are treated.